GB809046A - Improvements in or relating to steroids and the manufacture thereof - Google Patents
Improvements in or relating to steroids and the manufacture thereofInfo
- Publication number
- GB809046A GB809046A GB34342/56A GB3434256A GB809046A GB 809046 A GB809046 A GB 809046A GB 34342/56 A GB34342/56 A GB 34342/56A GB 3434256 A GB3434256 A GB 3434256A GB 809046 A GB809046 A GB 809046A
- Authority
- GB
- United Kingdom
- Prior art keywords
- pregnen
- dihydroxy
- alkyl
- produce
- hydroxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J75/00—Processes for the preparation of steroids in general
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Abstract
The invention comprises a 2-alkyl-11-oxygen-substituted progesterone represented by the formula: <PICT:0809046/IV (b)/1> in which R is an a -hydroxy, b -hydroxy or a keto group and the lower alkyl radical contains from 1-8 carbon atoms, inclusive, and a process comprising condensing an 11,20-dihydroxy-4-pregnen-3-one with a lower alkyl formate or a di-lower alkyl oxalate or a lower-alkyl trifluoroacetate in the presence of an alkali-metal condensing agent, to produce the alkali-metal enolate of a 2-carbonyl-11,20-dihydroxy-4-pregnen-3-one, alkylating the thus produced alkali metal enolate of 2-carbonyl-11,20-dihydroxy-4-pregnen-3-one with a lower alkyl halide wherein the halogen is chlorine, bromine or iodine, to produce a 2-alkyl-2-carbonyl-11,20-dihydroxy-4-pregnen-3-one, removing the 2-carbonyl group by reaction with an alkanol and an alkali-metal alkoxide to produce 2-alkyl-11,20 - dihydroxy - 4 - pregnen - 3 - one, oxidizing the 20-hydroxy group of the resulting 2 - alkyl - 11,20 - dihydroxy - 4 - pregnen - 3 - one to produce a 2-alkyl-11b -hydroxyprogesterone or, if desired, completely oxidizing to produce a 2-alkyl-11-keto-progesterone. The 11,20 - dihydroxy - 4 - pregnen - 3 - one is produced by reacting an 11-oxygenated progesterone with a secondary amine, reducing the resulting enamine with a reducing agent capable of reducing keto groups without affecting double bonds, e.g. lithium aluminium hydride, sodium aluminium hydride and diborane, to produce the 3 - enamine of 11b ,20 - dihydroxy - 4 - pregnen-3-one and then hydrolysing the latter compound. As secondary amine there may be used pyrrolidine, C-alkylpyrrolidines, piperidine or C-alkylpiperidines. Partial oxidation to obtain 2-alkyl-11b -hydroxyprogesterone may be effected by an Oppenauer oxidation or complete oxidation to obtain 2-alkyl-11-ketoprogesterone may be effected with chromic acid or sodium dichromate. Examples describe the preparation of the following intermediates and products, the 3-pyrrolidyl enamine of 11b , 20 - dihydroxy - 4 - pregnen - 3 - one, 11b ,20-dihydroxy - 4 - pregnen - 3 - one, sodium enolate of 2-methoxyoxalyl-11b ,20-dihydroxy-4 - pregnen - 3 - one, 2 - methyl - 2 - methoxyoxalyl - 11b ,20 - dihydroxy - 4 - pregnen - 3 - one, 2 - methyl - 11b ,20 - dihydroxy - 4 - pregnen - 3 - one, 2 - methyl - 11 - ketoprogesterone, and 2-methyl-11b -hydroxyprogesterone.ALSO:2 - Alkyl - 11 - oxygen - substituted - progesterones represented by the formula: <FORM:0809046/VI/1> in which R is an a -hydroxy, b -hydroxy or a keto group and the lower alkyl radical contains from 1-8 carbon atoms inclusive are useful orally as in tablets, or topically as in ointments, lotions, jellies, creams and aqueous suspensions for the treatment of arthritic conditions and as nervous system depressants.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US809046XA | 1955-11-16 | 1955-11-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB809046A true GB809046A (en) | 1959-02-18 |
Family
ID=22160392
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB34342/56A Expired GB809046A (en) | 1955-11-16 | 1956-11-09 | Improvements in or relating to steroids and the manufacture thereof |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB809046A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3156712A (en) * | 1961-09-05 | 1964-11-10 | American Home Prod | Preparation of 3beta-hydroxy-delta4-20-ketosteroids from steroidal delta4-3, 20-diketones |
-
1956
- 1956-11-09 GB GB34342/56A patent/GB809046A/en not_active Expired
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3156712A (en) * | 1961-09-05 | 1964-11-10 | American Home Prod | Preparation of 3beta-hydroxy-delta4-20-ketosteroids from steroidal delta4-3, 20-diketones |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CH614217A5 (en) | Process for the preparation of 1,3,5(10)-8alpha-oestratrienes | |
GB809046A (en) | Improvements in or relating to steroids and the manufacture thereof | |
GB1127747A (en) | Novel processes for the preparation of estratriene derivatives and compositions incorporating them | |
GB901293A (en) | Improvements in or relating to steroids | |
US2838490A (en) | 6-fluoro androstenes | |
GB898292A (en) | Improvements in or relating to steroids and the manufacture thereof | |
US2991295A (en) | 11beta-hydroxy-17alpha-alkyl estrogens and intermediates in the production thereof | |
US3759961A (en) | Process for ethinylating 17-ketosteroids | |
GB1141856A (en) | 19-nor-4,5-seco-steroids | |
US3099659A (en) | Steroidal lactones | |
US2870141A (en) | 6-fluoro-20-hydroxy-4-pregnen-3-ones and the 20-acylates thereof | |
US3689521A (en) | Organic compounds and processes | |
GB979898A (en) | New fused polycyclic hydrocarbon derivatives and processes for the preparation thereof | |
US2616903A (en) | Preparation of unsaturated steroid alcohols | |
US3689564A (en) | Steroids intermediates having a 17a-hydroxy-13-hydrocarbon substituted 8,14-secogona-1,3,5(10),9,15-pentaen-14-one nucleus | |
GB868303A (en) | New cyclopentanophenanthrene derivatives and process for the production thereof | |
GB878725A (en) | Pregnenolone derivatives and processes for their production | |
GB1022042A (en) | Improvements in or relating to steroids and the manufacture thereof | |
GB948631A (en) | Cyclopentanophenanthrene derivatives and process for their production | |
GB532262A (en) | Process for hydrating acetylene derivatives of the cyclopentanopolyhydrophenanthrene series | |
GB491799A (en) | Manufacture of derivatives of cyclopentano-polyhydrophenanthrene | |
GB748824A (en) | Cyclopentanophenanthrene derivatives and process for the preparation thereof | |
GB809485A (en) | Improvements in or relating to steroids and the manufacture thereof | |
GB921156A (en) | Synthesis of steroids | |
GB806047A (en) | Improvements in or relating to steroids and the manufacture thereof |